2021 will see the introduction of Australia’s first cell-based influenza vaccine, Flucelvax Quad (Quadrivalent influenza vaccine (surface antigen, inactivated, prepared in cell cultures)).
This session will cover the rationale for cell-based influenza vaccines and practical considerations for pharmacists. |